SHFE silver front-month contract fell more than 3% to 14,230 yuan/kg.

Zhongji Xuchuang on July 12 denied market rumors that its Q2 results would be materially below expectations and that the company has been deliberately suppressing its share price. The company said the Q2-miss allegation is baseless, noted it has not yet issued an earnings preview or its H1 2026 report, and said it is confident in H1 2026 operating performance and industry demand. It also denied intentionally delaying revenue recognition or manipulating results and said it routinely protects its capital-market image and investors’ interests.

A股创新药板块走高，立方制药、哈药股份涨停，陇神戎发、万邦医药涨超10%，新天地、以岭药业、双鹭药业、昊帆生物、海正药业跟涨。